A Study of Aerobic Exercise for Patients With Bipolar Disorder

Sponsor
Guangzhou Psychiatric Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03353337
Collaborator
(none)
210
1
2
25
8.4

Study Details

Study Description

Brief Summary

This study will investigate the effects of aerobic exercise on mental states, cognition, BDNF, and long-term outcomes in patients with bipolar disorder.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: aerobic exercise
  • Behavioral: Placebo controlled group
N/A

Detailed Description

Multiple cognitive impairments are common in patients with bipolar disorder. Preliminary evidence shows that aerobic exercise might have positive effects in enhancing cognition and improving clinical symptoms in patients with mood disorders. This randomized controlled trial will investigate short-term (1 months) effects of aerobic exercise on cognition and clinical symptoms as well as the long-term (12 months) effects on decreasing the recurrence rate.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
210 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomised Controlled Trial of Aerobic Exercise for Inpatients With Bipolar Affective Disorder
Anticipated Study Start Date :
Dec 1, 2017
Anticipated Primary Completion Date :
Jul 31, 2019
Anticipated Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: aerobic exercise

Cycling at the intensity of 50%-70% of maximum heart rate (220-age) for 30 mins per day, 4 days per week, last for 1 month.

Behavioral: aerobic exercise
Cycling at the intensity of 50%-70% of maximum heart rate (220-age) for 30 mins per day, 4 days per week, last for 1 months.

Placebo Comparator: Placebo controlled group

General intensity activities of recreation therapy, including Handicraft manufacture, reading activity, singing entertainment, walking.

Behavioral: Placebo controlled group
General intensity activities of recreation therapy, including Handicraft manufacture, reading activity, singing entertainment, walking.

Outcome Measures

Primary Outcome Measures

  1. Changes in neurocognitive function [12 months]

    Changes in neurocognitive function measured by the MATRICS Consensus Cognitive Battery (MCCB) after three months (12 weeks) of aerobic exercise

  2. Changes in neurocognitive function [Changes in neurocognitive function measured by the MATRICS Consensus Cognitive Battery (MCCB) after three months (12 weeks) of aerobic exercise]

    Changes in neurocognitive function measured by the MATRICS Consensus Cognitive Battery (MCCB) after three months (12 weeks) of aerobic exercise

Secondary Outcome Measures

  1. relapse rate [12 months]

    Relapses of depressive and/or hypo/manic episodes

  2. depressive symptoms [4 weeks, 4 months, 12 months]

    depressive symptoms measured by Hamilton Depression Scale

  3. manic symptom [4 weeks, 4 months, 12 months]

    manic symptom measured by Young Manic Rating Scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • DSM-IV defined bipolar disorder.

  • Never accept aerobic exercise therapy.

  • dextromanuality.

Exclusion Criteria:
  • Diagnosed neurological or musculoskeletal disorder/injury,

  • Uncontrolled cardiovascular or metabolic diseases that are not suitable for running

  • Diagnosed hypertension

  • Other diagnosed serious medical conditions that are not suitable for cycling

  • Severe suicidal ideation

  • Mental retardation

  • Currently participating in a exercise program or activity, defined as 30 minutes of vigorous physical activity 4-5 times per week

Contacts and Locations

Locations

Site City State Country Postal Code
1 Guangzhou Brain hospital(Guangzhou Huiai Hospital) Guangzhou Guangdong China 510370

Sponsors and Collaborators

  • Guangzhou Psychiatric Hospital

Investigators

  • Principal Investigator: Kangguang Lin, MD, PhD, Guangzhou Brain hospital (Guangzhou Psychiatric Hospital)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kangguang Lin, MD,PhD, Guangzhou Psychiatric Hospital
ClinicalTrials.gov Identifier:
NCT03353337
Other Study ID Numbers:
  • GZ Psychiatric Hospital
First Posted:
Nov 27, 2017
Last Update Posted:
Nov 27, 2017
Last Verified:
Nov 1, 2017
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kangguang Lin, MD,PhD, Guangzhou Psychiatric Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 27, 2017